XRAY DENTSPLY SIRONA INC revenue, earnings and financials

For the quarter ended June 30, 2026, DENTSPLY SIRONA INC reported revenue of $898M (down 4.1% from a year earlier), net income of $37.0M and diluted EPS of $0.18; over the last four quarters revenue was $3.64B and net income −$546M; for the fiscal year ended December 2025 revenue was $3.68B, down 3.0% on the year before.

XRAY annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $3.68B, gross profit $1.84B, operating income −$422M, net income −$598M (margin -16.3%), EPS −$3.00
• Fiscal year ended Dec 2024: revenue $3.79B, gross profit $1.96B, operating income −$879M, net income −$910M (margin -24.0%), EPS −$4.48
• Fiscal year ended Dec 2023: revenue $3.97B, gross profit $2.09B, operating income −$85.0M, net income −$132M (margin -3.3%), EPS −$0.62
• Fiscal year ended Dec 2022: revenue $3.92B, gross profit $2.13B, operating income −$937M, net income −$950M (margin -24.2%), EPS −$4.41
• Fiscal year ended Dec 2021: revenue $4.23B, gross profit $2.35B, operating income $608M, net income $411M (margin 9.7%), EPS $1.87

XRAY quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $898M (down 4.1% year over year), net income $37.0M, EPS $0.18
• Quarter ended Mar 31, 2026: revenue $880M (up 0.1% year over year), net income −$10.0M, EPS −$0.05
• Quarter ended Dec 31, 2025 (from the annual report): revenue $961M (up 6.2% year over year), net income −$146M, EPS −$0.74
• Quarter ended Sep 30, 2025: revenue $904M (down 4.9% year over year), net income −$427M, EPS −$2.14
• Quarter ended Jun 30, 2025: revenue $936M (down 4.9% year over year), net income −$45.0M, EPS −$0.22
• Quarter ended Mar 31, 2025: revenue $879M (down 7.8% year over year), net income $20.0M, EPS $0.10
• Quarter ended Dec 31, 2024 (from the annual report): revenue $905M (down 10.6% year over year), net income −$430M, EPS −$2.09
• Quarter ended Sep 30, 2024: revenue $951M (up 0.4% year over year), net income −$494M, EPS −$2.46
• Quarter ended Jun 30, 2024: revenue $984M (down 4.3% year over year), net income −$4.00M, EPS −$0.02
• Quarter ended Mar 31, 2024: revenue $953M (down 2.6% year over year), net income $18.0M, EPS $0.09
• Quarter ended Dec 31, 2023 (from the annual report): revenue $1.01B (up 3.0% year over year), net income $67.0M, EPS $0.32
• Quarter ended Sep 30, 2023: revenue $947M (up 0.0% year over year), net income −$266M, EPS −$1.25
• Quarter ended Jun 30, 2023: revenue $1.03B (up 0.5% year over year), net income $86.0M, EPS $0.40
• Quarter ended Mar 31, 2023: revenue $978M (up 0.9% year over year), net income −$19.0M, EPS −$0.09
• Quarter ended Dec 31, 2022 (from the annual report): revenue $983M (down 10.9% year over year), net income −$15.0M, EPS −$0.06
• Quarter ended Sep 30, 2022: revenue $947M (down 8.9% year over year), net income −$1.08B, EPS −$5.01
• Quarter ended Jun 30, 2022: revenue $1.02B (down 3.7% year over year), net income $73.0M, EPS $0.34
• Quarter ended Mar 31, 2022: revenue $969M (down 5.6% year over year), net income $69.0M, EPS $0.32
• Quarter ended Dec 31, 2021: revenue $1.10B, net income $119M, EPS $0.54
• Quarter ended Sep 30, 2021: revenue $1.04B, net income $84.0M, EPS $0.38

XRAY cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $235M, share buybacks $0, dividends $0.64 per share
• Fiscal year ended Dec 2024: operating cash flow $461M, share buybacks $250M, dividends $0.64 per share
• Fiscal year ended Dec 2023: operating cash flow $377M, share buybacks $300M, dividends $0.56 per share
• Fiscal year ended Dec 2022: operating cash flow $517M, share buybacks $150M, dividends $0.50 per share
• Fiscal year ended Dec 2021: operating cash flow $657M, share buybacks $200M, dividends $0.43 per share

XRAY balance sheet

• Jun 30, 2026: cash $239M, total assets $5.20B, total liabilities $3.85B, shareholders' equity $1.35B, long-term debt $2.00B
• Mar 31, 2026: cash $190M, total assets $5.23B, total liabilities $3.91B, shareholders' equity $1.32B, long-term debt $2.01B
• Dec 31, 2025: cash $326M, total assets $5.43B, total liabilities $4.09B, shareholders' equity $1.34B, long-term debt $2.02B
• Sep 30, 2025: cash $363M, total assets $5.65B, total liabilities $4.18B, shareholders' equity $1.48B, long-term debt $2.02B
• Jun 30, 2025: cash $359M, total assets $6.07B, total liabilities $4.11B, shareholders' equity $1.96B, long-term debt $2.22B
• Mar 31, 2025: cash $398M, total assets $6.05B, total liabilities $4.04B, shareholders' equity $2.01B, long-term debt $1.59B
• Dec 31, 2024: cash $272M, total assets $5.75B, total liabilities $3.81B, shareholders' equity $1.94B, long-term debt $1.59B
• Sep 30, 2024: cash $296M, total assets $6.63B, total liabilities $4.14B, shareholders' equity $2.49B, long-term debt $1.80B

What is XRAY's revenue?

DENTSPLY SIRONA INC reported $3.64B of revenue over its last four quarters, through June 30, 2026.

Is XRAY profitable?

No. DENTSPLY SIRONA INC lost $546M over the last four quarters.

What is XRAY's EPS?

Diluted earnings per share over the last four quarters were −$2.75; $0.18 in the latest quarter.

Does XRAY pay a dividend?

DENTSPLY SIRONA INC paid $0.64 per share in dividends in the fiscal year ended December 2025.

XRAY ownership and insider trades · All stocks